Literature DB >> 7472500

Protein kinase C involvement in homologous desensitization of delta-opioid receptor coupled to Gi1-phospholipase C activation in Xenopus oocytes.

H Ueda1, T Miyamae, C Hayashi, S Watanabe, N Fukushima, Y Sasaki, T Iwamura, Y Misu.   

Abstract

We have developed the coexpression system of both delta-opioid receptor (DOR1) and M2-muscarinic receptor (M2) which mediate agonist-evoked currents due to common post-receptor mechanisms including Gi1 and phospholipase C (PLC) activation in Xenopus oocytes reconstituted with Gi1 alpha. The DOR1-currents by 100 nM D-Ser2-leu-enkephalin-Thr6 (DSLET) were selectively desensitized by 10 nM phorbol 12-myristate 13-acetate (PMA). The PMA-desensitization of DSLET-currents was abolished in the presence of calphostin C, a protein kinase C inhibitor, or reversed by an intracellular injection of calcineurin, a protein phosphatase 2B. When a higher concentration (3 microM) of DSLET was used, DSLET-currents were rapidly desensitized by repeated challenges of DSLET itself. However, repeated challenges of 10 microM ACh caused no influence on such DSLET- or M2-currents. The desensitization of DSLET-currents was selectively reversed by protein kinase C inhibitors. Similar results were also obtained with various delta-opioid agonists. These results suggest that protein kinase C is involved in the homologous desensitization of delta-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472500      PMCID: PMC6578054     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  7 in total

1.  Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.

Authors:  H Grimberg; I Zaltsman; M Lupu-Meiri; M C Gershengorn; Y Oron
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 2.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

3.  Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.

Authors:  H Ueda; M Inoue; T Matsumoto
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

4.  A critical protein kinase C phosphorylation site on the 5-HT(1A) receptor controlling coupling to N-type calcium channels.

Authors:  X Wu; N Kushwaha; P R Albert; N J Penington
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

5.  Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.

Authors:  Jing-Jun Zhou; Jin-Song Bian; Jian-Ming Pei; Song Wu; Hong-Yu Li; Tak-Ming Wong
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.

Authors:  M Narita; H Mizoguchi; J P Kampine; L F Tseng
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1.

Authors:  Reza N Sharif; Michael Osborne; Terence J Coderre; Marian E Fundytus
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.